A detailed history of Sage Private Wealth Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sage Private Wealth Group, LLC holds 1,016 shares of NVO stock, worth $103,367. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,016
Previous 1,016 -0.0%
Holding current value
$103,367
Previous $113,000 10.62%
% of portfolio
0.13%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

BUY
$103.24 - $121.81 $6,297 - $7,430
61 Added 6.39%
1,016 $113,000
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $8,751 - $10,578
94 Added 10.92%
955 $106,000
Q4 2021

Jan 24, 2022

BUY
$95.88 - $117.08 $287 - $351
3 Added 0.35%
861 $96,000
Q4 2020

Mar 02, 2021

BUY
$63.89 - $73.8 $54,817 - $63,320
858 New
858 $60,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sage Private Wealth Group, LLC Portfolio

Follow Sage Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Private Wealth Group, LLC with notifications on news.